New Publication: Bi-allelic variants of FILIP1 cause congenital myopathy, dysmorphism and neurological defects

Lochmüller Lab study on novel disease gene published in BRAIN: a journal of neurology.

Filamin-A-interacting protein 1 (FILIP1) is a structural protein that is involved in neuronal and muscle function and integrity. Our new paper shows that loss of functional FILIP1 causes a recessive disorder characterized by neurological and muscular manifestations as well as dysmorphic features accompanied by perturbed proteostasis and myopathology. While the filamin-encoding genes FLNA and FLNC have previously been linked to neurological and muscle disorders, this is the first time FILIP1 has been associated with human disease.

 

Bi-allelic variants of FILIP1 cause congenital myopathy, dysmorphism and neurological defects is now available in BRAIN: a journal of neurology. The publication is authored by associated scientist Andreas Roos together with Kaela O’Connor and Hanns Lochmüller. 

 

The publication reports on five patients from four unrelated families presenting with neurological and muscular symptoms who have bi-allelic variants in FILIP1. With these case reports and several characterization studies on the investigated variants, FILIP1 was identified as a novel genetic cause for a cluster of congenital neuropediatric symptoms. This identification provides a genetic diagnosis for the five patients involved in this research, and highlights FILIP1 as a potential cause for undiagnosed patients with similar symptoms.

Our lab performed in silico studies on the identified missense variants to predict alterations to the non-covalent interactions within the protein structure, and to predict changes to protein stability.

 

How to Find the Publication

This paper is not open access; If you do not have access through your institution, please contact Dr Hanns Lochmüller to obtain a full-text version.

 

Reference

Roos, A., van der Ven, P. F. M., Alrohaif, H., Kölbel, H., Heil, L., Della Marina, A., Weis, J., Aßent, M., Beck-Wödl, S., Barresi, R., Töpf, A., O’Connor, K., Sickmann, A., Kohlschmidt, N., El Gizouli, M., Meyer, N., Daya, N., Grande, V., Bois, K., Kaiser, F. J., … Lochmüller, H. (2023). Bi-allelic variants of FILIP1 cause congenital myopathy, dysmorphism and neurological defects. Brain : a journal of neurology, awad152. Advance online publication. https://doi.org/10.1093/brain/awad152

 

Abstract

Filamin-A-interacting protein 1 (FILIP1) is a structural protein that is involved in neuronal and muscle function and integrity and interacts with FLNa and FLNc. Pathogenic variants in filamin-encoding genes have been linked to neurological disorders (FLNA) and muscle diseases characterized by myofibrillar perturbations (FLNC), but human diseases associated with FILIP1 variants have not yet been described. Here, we report on five patients from four unrelated consanguineous families with homozygous FILIP1 variants (two nonsense and two missense). Functional studies indicated altered stability of the FILIP1 protein carrying the p.[Pro1133Leu] variant. Patients exhibit a broad spectrum of neurological symptoms including brain malformations, neurodevelopmental delay, muscle weakness and pathology, and dysmorphic features. Electron and immunofluorescence microscopy on the muscle biopsy derived from the patient harbouring the homozygous p.[Pro1133Leu] missense variant revealed core-like zones of myofibrillar disintegration, autophagic vacuoles and accumulation of FLNc. Proteomic studies on the fibroblasts derived from the same patient showed dysregulation of a variety of proteins including FLNc and alpha-B-crystallin, a finding (confirmed by immunofluorescence) which is in line with the manifestation of symptoms associated with the syndromic phenotype of FILIP1opathy. The combined findings of this study show that the loss of functional FILIP1 leads to a recessive disorder characterized by neurological and muscular manifestations as well as dysmorphic features accompanied by perturbed proteostasis and myopathology. 

K_OCONNOR_model_pic

Read next...

Congratulations Dr Hanns Lochmuller, Department of medicine researcher of the year 2024. Photo of Hanns and lab members receiving the award.

Dr. Hanns Lochmüller Awarded “Researcher of the Year” by University of Ottawa and The Ottawa Hospital Department of Medicine

We are delighted to announce that Hanns is this year's winner of the Researcher of the Year award conferred by the University of Ottawa/The Ottawa...
New Publication: Partial loss of desmin expression due to a leaky splice site variant in the human DES gene is associated with neuromuscular transmission defects

New Publication: Partial loss of desmin expression due to a leaky splice site variant in the human DES gene is associated with neuromuscular transmission defects 

Desmopathies are predominantly autosomal dominant neuromuscular conditions causing adult onset myofibrillar myopathy or cardiomyopathy due to heterozygous DES (DESMIN; OMIM: 125660) mutations. Recessive desminopathies caused...
We are hiring a new clinical research coordinator!

Lochmüller Research Group Hiring Clinical Trial Coordinator

Due to recent funding success and expansion of our clinical trials team we have a need for a highly motivated Research Coordinator that will assist...
First participant screened in global CMS natural history study

The Ottawa Neuromuscular Centre screens first participant in the world for a multinational congenital myasthenic syndrome natural history study

The neuromuscular centre at The Ottawa Hospital is excited to announce that we are the first site globally to screen a participant for the multinational...
Copy of Lochmuller Lab - PhD opportunity (LLab)

Lochmüller Lab seeking PhD student

The Lochmüller Research Group are seeking a highly motivated PhD student to join our team at the Childrens Hospital of Eastern Ontario Research Institute (CHEO...
New Publication - Leading global expert in DMD and bone health Dr. Leanne Ward publishes systematic review and grading of evidence for biphosphonate therapy in glucocorticoid-treated patients with Duchenne Muscular Dystrophy in Neurology, with Dr. Hanns Lochmüller as a co-author.

New Publication: Bisphosphonates in Glucocorticoid-Treated Patients with Duchenne Muscular Dystrophy: A Systematic Review and Grading of the Evidence

Leading global expert in Duchenne Muscular Dystrophy (DMD) and bone health Dr. Leanne Ward publishes systematic review and grading of evidence for bisphosphonate therapy in...